Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

iScience

Topics

Biology

Immunology

Medicine

Internal Medicine

Infectious Diseases

Show all topics

DOI

10.1016/j.isci.2024.110728

License

CC-BY